NCT06704360Not yet recruiting
Efficacy and Safety of Immersive Virtual Reality for Post-stroke Cognitive Impairment
A Single-blind Randomized Controlled Trial to Evaluate Efficacy and Safety of Immersive Virtual Reality for Post-stroke Cognitive Impairment
Source: ClinicalTrials.gov · Last updated 26 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a single-blind randomized controlled trial to evaluate the efficacy and safety of immersive virtual reality for post-stroke cognitive impairment.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 21 Nov 2024
- Start date
- 1 Dec 2024
- Primary completion date
- 1 Nov 2025
- Lead sponsor
- Dingqun Bai
- Diseases
- Stroke
- NCT number
- NCT06704360
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 1 Dec 2024 to the primary completion date, 1 Nov 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- is participating in another clinical trial involving an investigational drug or physical therapy
Other illness
- The test could not be tolerated due to organic disease
- There is a serious mental illness resulting in inability to cooperate with or tolerate this test
Other
- Patients who have not signed informed consent
Who the study is looking for
- Diagnosis of stroke by neuroimaging (CT or MRI) assessment
- 18-85 years old
- Be able to follow instructions to complete the test
- Can tolerate the rehabilitation training of this experiment
- First stroke
- Patients who signed informed consent
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.